Khanban, H. et al. 2019. In vivo administration of G9a inhibitor A366 decreases osteogenic potential of bone marrow-derived mesenchymal stem cells. EXCLI Journal. 18, (Jun. 2019), 300–309. DOI:https://doi.org/10.17179/excli2019-1234.